IgG-RBD Response Due to Inactivated SARS-CoV-2 Vaccine: Alteration in D-Dimer and Fibrinogen Concentrations, Association with Comorbidities and Adverse Effects

Lab Med. 2022 Nov 3;53(6):590-595. doi: 10.1093/labmed/lmac047.

Abstract

Objective: To examine the immunoglobulin G-receptor-binding domain (IgG-RBD) response and changes in fibrinogen and D-dimer concentrations in individuals with a past coronavirus infection and followed by CoronaVac.

Methods: The study consisted of a total of 116 participants. Blood samples were drawn from subjects 21-25 days after they received first and second doses of CoronaVac as well as from individuals with a past infection. Fibrinogen, D-dimer, and IgG-RBD concentrations were measured.

Results: The IgG concentrations of the vaccinated subjects were significantly higher (P < .001), fibrinogen levels were lower (P < .001), and D-dimer levels increased following the second vaccination compared with the first vaccination (P = .083). No difference was obtained in IgG-RBD between vaccinated and previously infected individuals (P = .063). The differences in fibrinogen and D-dimer were statistically nonsignificant between both groups.

Conclusion: The CoronaVac vaccine appears to be safe and effective. It is essential for individuals to take personal protective measures, such as using masks and distancing.

Keywords: COVID-19 infection; D-dimer; fibrinogen; side effects; vaccination.

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Fibrinogen
  • Humans
  • Immunoglobulin G
  • Receptors, IgG
  • SARS-CoV-2
  • Viral Vaccines*

Substances

  • COVID-19 Vaccines
  • fibrin fragment D
  • Fibrinogen
  • Receptors, IgG
  • Viral Vaccines
  • Immunoglobulin G